Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Can-Fite BioPharma Ltd.

    AMEX: CANF · Real-Time Price · USD
    0.66
    -0.01 (-1.79%)
    At close: Aug 15, 2025, 3:59 PM
    0.65
    -1.62%
    After-hours: Aug 15, 2025, 07:19 PM EDT

    Can-Fite BioPharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Net Income
    		 -1.96M -1.96M -1.98M -1.98M -1.65M -1.76M -1.67M -2.55M -3.02M -2.53M -2.19M -2.43M -4.12M -3.4M -3.22M -1.88M
    Depreciation & Amortization
    		 3K 3K 500.00 500.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Stock-Based Compensation
    		 84.5K 84.5K 96.5K 96.5K 261K -95K 95K n/a 263K -135K 135K n/a 466K -234K 234K n/a
    Other Working Capital
    		 267.5K 267.5K -322K -322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Non-Cash Items
    		 -194K -194K 185.5K 185.5K 1.39M 1.86M 1.57M 2.55M 2.76M 2.66M 2.06M 2.43M 3.65M 3.63M 2.98M 1.88M
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 267.5K 267.5K -322K -322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Cash Flow
    		 -1.8M -1.8M -2.02M -2.02M n/a -95K 95K n/a 263K -135K 135K n/a n/a n/a n/a n/a
    Capital Expenditures
    		 -500 -500 -2K -2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 -1.5M -1.5M 2.25M 2.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 -1.5M -1.5M 2.25M 2.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 3.36M 3.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Financial Cash Flow
    		 3.36M 3.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Net Cash Flow
    		 n/a n/a n/a n/a n/a -95K 95K n/a 263K -135K 135K n/a n/a n/a n/a n/a
    Free Cash Flow
    		 -1.8M -1.8M -2.02M -2.02M n/a -95K 95K n/a 263K -135K 135K n/a n/a n/a n/a n/a

    Add to Watchlist